PremiumCompany AnnouncementsbioAffinity Technologies Reports Strong Q1 2025 Growth bioAffinity Technologies Completes $3.2M Public Offering BioAffinity Technologies announces closing of $3.25M offering PremiumThe FlyBioAffinity Technologies downgraded to Hold from Buy at Maxim BIAF Upcoming Earnings Report: What to Expect? BioAffinity accelerates CyPath Lung amid $4M in annual cost savings at PPLS PremiumThe FlyBioAffinity Technologies files to sell 2.72M shares of common stock for holders bioAffinity Technologies Reports Strong Q3 Growth BioAffinity Technologies reports Q3 EPS (16c), consensus (15c)